Avani A Narayan, MS

CONTACT

Laura A Dapkus Humphries, NCPT

CONTACT

Lead Sponsor

University of California, San Francisco

Collaborators

Age

10 - 21 years

Sex

ALL

Healthy Volunteers

No

•Age 10- 21 years
•Diagnosis of T2D based on clinical diagnosis or ICD 9 and 10 codes
•Duration of T2D ≥ 3 months
•HbA1C ≥ 7% which is the target HbA1C recommended by the American Diabetes Association
•Stable medication regimen (No medication changes and no change in basal insulin dose by more than 20% in the 2 weeks prior to enrollment)
•Ability to wear CGM for a total of 6 weeks while in the study.
•English or Spanish speakers.
•Willing to abide by recommendations and study procedures.
•Willing and able to sign the Informed Consent Form (ICF) and/or has a parent or guardian willing and able to sign the ICF.

•Pancreatic autoantibody positivity (GAD-65, insulin, IA-2, ICA 512, ZnT8).
•Plan for undergoing bariatric surgery during the study period
•Anticipated use of systemic glucocorticoids during the study period
•Unable to stop taking more than 500mg/day of Vitamin C during the study period as this may affect the sensor readings.
•Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data.
•Presence of a condition or abnormality that in the opinion of the Investigator would cause repeated hospitalizations or significant changes in medications.